Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Views - The company is undergoing a transformation towards innovation, with results expected to materialize soon. The impact of centralized procurement on existing generic and traditional Chinese medicine businesses is gradually diminishing, while the industrial microbiology and medical aesthetics segments are expected to contribute to revenue growth. Overall, the company's performance is projected to grow steadily, and the realization of innovation may lead to a revaluation of its value [7]. - The company has over 80 innovative drug candidates in its pipeline, focusing on endocrine, autoimmune, and oncology fields. The innovative products are expected to be launched and contribute to revenue starting in 2025, enhancing the sales system for innovative drugs [7]. - The industrial microbiology and medical aesthetics segments are forming a diversified growth engine. The company has established a strategic layout in industrial microbiology and is expected to achieve rapid growth as customer orders convert into production capacity. The medical aesthetics segment is also anticipated to recover quickly with the launch of new products [7]. Summary by Sections 1. Company Overview - Established in 1993, the company has developed into a large-scale comprehensive pharmaceutical enterprise covering the entire pharmaceutical industry chain, including pharmaceutical manufacturing, commercial distribution, medical aesthetics, and industrial microbiology [13]. - The company has shifted its focus from generic drug development to innovation-driven strategies since 2018, with a strong emphasis on endocrine, autoimmune, and oncology treatment areas [13]. 2. Financial Performance - The company's total revenue is projected to grow from 40,624 million in 2023 to 52,228 million in 2027, with a compound annual growth rate (CAGR) of 11.64% from 2010 to 2024. The net profit attributable to shareholders is expected to increase from 2,839 million in 2023 to 5,154 million in 2027 [1][20]. - The company's gross profit margin and net profit margin have improved, with gross profit margin rising from 24.27% in 2016 to 33.31% in 2024 [23]. 3. Innovation and R&D - The company has established a comprehensive drug research and development system, focusing on innovative drug candidates in the fields of oncology, endocrine, and autoimmune diseases. The R&D pipeline includes over 80 projects, with significant progress in clinical trials for several innovative products [26][32]. - The company has significantly increased its R&D investment, with the number of researchers growing from 550 in 2018 to 1,864 in 2024, and R&D expenditure rising from 707 million in 2018 to 1,770 million in 2023 [29]. 4. Market Position and Growth Potential - The company is well-positioned in the GLP-1 receptor agonist market, with several innovative products in various stages of clinical development. The global market for GLP-1 drugs is expected to grow significantly, providing a substantial opportunity for the company [39][46]. - The medical aesthetics segment is also expected to contribute to growth, with the company expanding its international and high-end product offerings [7].

2025 年 06 月 09 日 证券分析师 房诚琦 证券研究报告·行业跟踪周报·房地产 房地产行业跟踪周报 新房二手房成交同环比回落，城市更新政策持 续释放动能 增持（维持） 执业证书：S0600522100002 fangcq@dwzq.com.cn 行业走势 -17% -12% -7% -2% 3% 8% 13% 18% 23% 28% 33% 2024/6/11 2024/10/10 2025/2/8 2025/6/9 房地产 沪深300 相关研究 《新房成交面积环比改善，二手房成 交同比持续正增》 2025-06-04 《LPR 下调 10 基点，持续推进城市更 新》 2025-05-26 东吴证券研究所 1 / 17 请务必阅读正文之后的免责声明部分 [Table_Tag] [Table_Summary] ◼ 投资要点 ◼ 上周（2025.6.3-2025.6.6）：上周房地产板块（中信）涨跌幅 0.9%,同期沪 深 300、万得全 A 指数涨跌幅分别为 0.9%、1.6%，超额收益分别为 0.0%、 -0.7%。29 个中信行业板块中房地产位列第 20。 ◼ （1）新房市场：上周 36 城新房成 ...

Investment Rating - The report maintains a positive outlook on the automotive sector, emphasizing the potential for growth driven by technology innovation and market dynamics [2][3]. Core Insights - The automotive industry is expected to benefit from three main themes: AI, robotics, and favorable market conditions. The report suggests that technological innovation is crucial for the industry to escape the price war dilemma [3][49]. - The report forecasts a retail sales volume of 23.69 million units for 2025, representing a year-on-year growth of 4.1% [49]. - The penetration rate of new energy vehicles is projected to reach 60.6% by 2025, with sales expected to increase significantly [52][53]. Summary by Sections Weekly Review - In the fifth week of May, retail sales of passenger vehicles reached 458,000 units, reflecting a week-on-week increase of 17.1% and a month-on-month increase of 10.1% [2][48]. - The report highlights significant developments in the industry, including collaborations between companies like XPeng and Huawei, and advancements in autonomous driving technology [2][3]. Market Performance - The automotive sector ranked 25th in A-shares and 12th in Hong Kong stocks for the week, indicating moderate performance compared to other sectors [7][9]. - The report notes that the motorcycle segment performed the best within the automotive sector, with a weekly increase of 3.6% [15]. Industry Trends - The report emphasizes the importance of technological advancements, particularly in AI and robotics, as key drivers for the automotive industry's future growth [3][54]. - The report anticipates a strong demand for heavy trucks in 2025, with an expected increase in domestic sales and exports [54][59]. Company Focus - Key companies mentioned include XPeng, Ideal Automotive, and BYD, which are expected to lead in the adoption of AI and smart technologies [3][52]. - The report also highlights investment opportunities in companies involved in robotics and AI, such as Top Group and Jieneng Electronics [64].

Investment Rating - The report maintains a rating of "Overweight" for the non-ferrous metals sector [1]. Core Views - The non-ferrous metals sector experienced a weekly increase of 3.74%, ranking it second among all primary industries. The industrial metals segment saw a rise due to optimistic macroeconomic sentiments following the U.S. non-farm payroll data [1][15]. - The report highlights that while industrial metals are showing strength, there are underlying concerns regarding demand, particularly for copper and aluminum, which are facing seasonal slowdowns [2][37]. Summary by Sections Market Review - The Shanghai Composite Index rose by 1.13%, with 25 out of 31 sectors increasing. The non-ferrous metals sector outperformed the index by 2.61 percentage points [15]. - The small metals and new materials sectors saw increases of 5.07% and 5.15%, respectively, while industrial metals rose by 3.24% [15]. Industrial Metals - **Copper**: Prices for copper increased, with LME copper at $9,671 per ton (up 1.83%) and SHFE copper at ¥78,930 per ton (up 1.71%). However, downstream demand is weakening, leading to inventory accumulation [2][32]. - **Aluminum**: LME aluminum prices reached ¥2,452 per ton (up 0.12%), while SHFE aluminum remained stable at ¥20,070 per ton. Demand is declining, limiting upward price movement [3][37]. - **Zinc**: Zinc prices increased, with LME zinc at $2,663 per ton (up 1.25%) and SHFE zinc at ¥22,385 per ton (up 0.72%). Inventory levels showed mixed trends [42]. - **Tin**: Tin prices rose significantly, with LME tin at $32,255 per ton (up 6.70%) and SHFE tin at ¥263,600 per ton (up 5.31%) due to supply disruptions [45]. Precious Metals - **Gold**: COMEX gold closed at $3,331.10 per ounce (up 0.54%), while SHFE gold was at ¥783.24 per gram (up 2.48%). The market is reacting to mixed economic signals, with recent non-farm payroll data providing temporary relief from recession fears [4][48].

1. Report Industry Investment Rating No relevant content provided. 2. Core Views of the Report - The new policies on science - innovation bonds aim to guide bond market funds towards early - stage, small - medium enterprises, long - term projects, and hard - tech fields, enhancing innovation vitality and nurturing new productive forces [1][14]. - The policies expand the issuer scope, optimize bond terms, streamline issuance processes, and innovate credit assessment and risk - sharing mechanisms, covering all financing needs in the science - tech industry chain [2][15]. - Compared with previous policies, the new ones broaden the issuer scope to include financial institutions and PE/VCs, and make the use of raised funds more flexible [2][17]. - Financial institutions, including banks, securities firms, and investment companies, are expected to benefit from the new policies, with different impacts on each type of institution [2][34]. - The current situation of financial institutions issuing science - innovation bonds shows characteristics such as large - scale issuance by commercial banks, high - grade bond ratings, medium - short - term maturity concentration, and low financing costs [7][38]. 3. Summary by Directory 3.1 2025 May 7 New Package of Policies on Science - Innovation Bonds Interpretation 3.1.1 Science - Innovation Bond System Launched, Science - Finance System Upgraded - On May 7, 2025, the central bank and CSRC jointly issued Announcement No. 8, which guides funds to key areas, improving the current situation of the science - innovation bond market [1][14]. - The exchanges and NAFMII issued corresponding notices to implement the policies, including expanding issuer scope, optimizing bond terms, and innovating credit assessment and risk - sharing mechanisms [1][15]. 3.1.2 Comparison between New and Previous Policies - The new policies expand the issuer scope to financial institutions and PE/VCs, and support long - term bond issuance by PE/VCs, strengthening support for the entire life cycle of tech enterprises [2][17]. - The use of raised funds is more flexible, with different requirements for different markets and issuer types [2][18]. 3.2 Trends of Financial Institutions Issuing Science - Innovation Bonds under New Policies 3.2.1 Advantages and Impacts of New Policies on Financial Institutions Issuing Science - Innovation Bonds - **Advantages**: Provide institutional and practical convenience in terms of issuance qualification, investment - financing methods, and supporting mechanisms [29]. - **Impact on different institutions**: - Securities firms are key beneficiaries, expanding underwriting business, optimizing asset allocation, and upgrading business models [2][34]. - Commercial banks can extend service chains and support the entire life cycle of tech enterprises [2][35]. - Financial asset investment institutions can shift from bad - asset management to tech investment - financing, playing a complementary role [36]. - PE/VCs gain new financing and exit channels, enhancing capital operation efficiency and project support ability [37]. 3.2.2 Current Situation of Financial Institutions Issuing Science - Innovation Bonds - **Issuance scale**: In May 2025, financial institutions issued 45 science - innovation bonds worth 222.4 billion yuan, pushing the market's total outstanding scale to over 2.1 trillion yuan [7][38]. - **Issuer type**: Commercial banks are the main issuers, with large - scale issuance by state - owned banks, followed by policy banks and securities firms [7][40]. - **Bond rating**: Most bonds are rated AAA, which helps attract investors and ease the financing difficulties of small - medium tech enterprises [7][43]. - **Issuance term**: The terms range from half - year to ten - year, mainly concentrated in the medium - short term, especially 3 - year bonds. The term may be extended as financial institutions get more involved [7][47]. - **Use of raised funds**: Funds are mainly used to support tech enterprises in different investment forms, with a high proportion for loans, and the "tech content" is higher than before [7][54]. - **Issuance terms**: Over 90% of new bonds have no special terms, with less flexibility compared to those issued by real - economy enterprises [7][56]. - **Bond coupon rate**: The average coupon rate is about 1.81%, over 90BP lower than the previous average, reducing the financing cost of tech enterprises [7][59].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [1]. Core Views - The company is a leading one-stop provider of home meal products, focusing on retail stores and aiming to expand its store count significantly by 2025 [9][15]. - The market for home meal products is substantial, with a size of approximately 400 billion yuan, and the company holds a 3% market share, leading the competition [9][60]. - The company has a strong supply chain and is expanding its product offerings beyond hot pot ingredients to include barbecue and Western cuisine [9][28]. - The company plans to open an additional 10,000 stores over the next five years, with a focus on rural markets where competition is limited [9][18]. Summary by Sections 1. Leading One-Stop Home Meal Provider - The company has transitioned to a consumer-focused retail model since 2017, achieving rapid store growth [17]. - It has established a strong brand presence and is recognized for its affordable pricing strategy [15]. 2. Business Model: Vertical Industry in a Large Market - The company operates primarily through a franchise model, with 84% of revenue coming from sales to franchisees [24]. - The market for home meal products is fragmented, with the company being the largest player in a competitive landscape [60]. 3. Future Potential: Revenue Growth and Store Expansion - The company has successfully improved same-store sales and plans to continue expanding its store network [9][18]. - Revenue forecasts for 2025-2027 are projected at 72.83 billion yuan, 83.42 billion yuan, and 94.43 billion yuan, respectively, with corresponding net profits of 3.29 billion yuan, 4.00 billion yuan, and 4.95 billion yuan [1]. 4. Profit Forecast and Investment Recommendations - The report anticipates a recovery in single-store revenue and a positive outlook for store expansion, with a projected PE ratio decreasing from 24 to 16 over the forecast period [1][9].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [9]. Core Views - The company is a leading one-stop provider of home meal products, focusing on retail stores and aiming to expand its store count significantly by 2025 [15][18]. - The market for home meal products is substantial, with a size of approximately 400 billion yuan, and the company holds a 3% market share, leading the industry [9][60]. - The company has a strong supply chain and brand positioning, which enhances its competitive advantage in the fragmented market [9][60]. Summary by Sections 1. Company Overview - The company has transitioned to a consumer-focused retail model since 2017, rapidly expanding its store count to over 10,000 by the end of 2024 [17][18]. - It operates primarily through a franchise model, with a low investment requirement for franchisees, making it an attractive business opportunity [9][24]. 2. Business Model - The company’s business model leverages a large market with significant fragmentation, allowing it to capture a leading position through its extensive store network [58][60]. - The product offerings include a variety of meal solutions, with hot pot ingredients currently dominating the product mix [28][29]. 3. Future Growth Potential - The company plans to open an additional 10,000 stores over the next five years, focusing on rural markets where competition is limited [9][18]. - Single-store revenue recovery is expected to continue, supported by new product launches and marketing strategies [9][18]. 4. Financial Forecast and Investment Recommendations - Revenue projections for 2025-2027 are estimated at 72.83 billion yuan, 83.42 billion yuan, and 94.43 billion yuan, respectively, with corresponding net profits of 3.29 billion yuan, 4.00 billion yuan, and 4.95 billion yuan [9][18]. - The report anticipates a price-to-earnings ratio of 24, 20, and 16 for the years 2025, 2026, and 2027, respectively, indicating a favorable valuation outlook [9][18].

M&A Dynamics - From June 3 to June 8, there were 63 merger and acquisition (M&A) events involving listed companies, with 16 classified as significant M&A events[9] - Out of the total M&A events, 9 were completed, including 1 significant M&A[9] Policy Updates - The People's Bank of China emphasized the need to optimize systems for listings, M&A, and equity incentives based on technological innovation characteristics[7] - The Shanghai Stock Exchange plans to encourage listed companies to increase dividend payouts and enhance market value management tools[7] Major M&A Events - Notable M&A transactions included Baota Industrial acquiring 100% of Electric Power Investment New Energy for CNY 80,927,000[13] - A total of 4 M&A events involved state-owned enterprises as acquirers during the reporting period[13] M&A Failures - There were 3 failed M&A attempts, including a significant transaction by Guangdong Hongyuan due to a lack of consensus on the final transaction plan[15][17] - The failed transactions involved a total value of CNY 19,800,000 for one of the deals[17] Control Changes - Three companies reported changes in actual control, including Jinzi Ham and Diou Home, with the changes occurring between May 30 and June 5, 2025[19] Market Performance - The restructuring index underperformed the Wind All A index by -0.12% during the reporting period[21] - Over a mid-term view, the restructuring index showed fluctuations within a positive range compared to the Wind All A index[21] Risk Factors - Economic recovery in China is slower than expected, which may increase market uncertainty[26] - Geopolitical risks and uncertainties regarding U.S. policies towards China could negatively impact A-share liquidity[26]

证券研究报告·固定收益·固收周报 固收周报 20250609 央行提前预告买断式逆回购，关注流动性宽 松对于短端利率下行的支撑 [Table_Tag] [Table_Summary] 观点 我们在延续上周观点的基础上，结合增量数据，思考如下： （1）Markit 制造业与服务业 PMI 终值同步扩张，通胀压力增加，新增 2025 年 06 月 09 日 证券分析师 徐沐阳 证券分析师 李勇 执业证书：S0600519040001 010-66573671 liyong@dwzq.com.cn 执业证书：S0600523060003 证券分析师 陈伯铭 xumy@dwzq.com.cn 执业证书：S0600523020002 chenbm@dwzq.com.cn 证券分析师 徐津晶 执业证书：S0600523110001 xujj@dwzq.com.cn 相关研究 《建议关注核心科技题材转债》 2025-06-08 《绿色债券周度数据跟踪（20250602- 20250606）》 2025-06-07 东吴证券研究所 1 / 37 请务必阅读正文之后的免责声明部分 ◼ 央行提前预告买断式逆回购，重启买入国债讨论 ...

Investment Rating - The report maintains a rating of "Buy" for the utility sector [1]. Core Insights - The report emphasizes the potential for value reassessment of photovoltaic (PV) assets, particularly through the integration of green electricity direct connection and physical asset tokenization [2]. - It highlights the government's push for green electricity direct connection, mandating that self-generated renewable energy should account for at least 60% of total available generation [5]. - The report identifies key investment opportunities across various segments of the utility sector, including thermal, hydro, nuclear, and green energy [2]. Summary by Sections 1. Electricity Consumption - In the first four months of 2025, total electricity consumption reached 3.16 trillion kWh, reflecting a year-on-year increase of 3.1%, with notable growth in the primary industry at 10.0% [14][15]. 2. Power Generation - Cumulative power generation for the same period was 2.98 trillion kWh, showing a slight year-on-year increase of 0.1%. The generation from thermal, hydro, nuclear, wind, and solar sources varied, with solar power seeing a significant increase of 19.5% [25][26]. 3. Electricity Prices - The average electricity purchase price in May 2025 was 394 RMB/MWh, down 3% year-on-year but up 0.4% month-on-month [42]. 4. Thermal Power - The price of thermal coal at Qinhuangdao port was 609 RMB/ton as of June 6, 2025, reflecting a year-on-year decrease of 30.2% [47]. - The cumulative installed capacity of thermal power reached 1.46 billion kW, with a year-on-year increase of 4.1% [49]. 5. Hydropower - The water level at the Three Gorges Reservoir was 153 meters, consistent with previous years, indicating stable hydrological conditions [55]. - The cumulative installed capacity of hydropower was 440 million kW, with a year-on-year increase of 3.0% [57]. 6. Nuclear Power - In 2024, 11 new nuclear units were approved, indicating a steady growth trajectory for the nuclear sector [26]. 7. Green Energy - The report highlights the collaboration between GCL-Poly and Ant Group on a 200 million RMB photovoltaic RWA project, marking a significant step in the digital financing of green assets [5].